oral semaglutide obesity 50 mg of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://t.co/EFnRupKFV7 Novo Nordisk on X: "#PRESS

Management of Side Effects : Practitioners should emphasize the importance of reporting adverse effects, which can help manage these reactions promptly and appropriately

Even if you're not hungry, don't forego eating because your body still needs nutrients

You develop allodynia accompanied by vision changes, balance problems, or difficulty speaking

Sitagliptin is prescribed to people with type 2 diabetes, and is usually taken alongside a healthy diet and regular, appropriate exercise to help control diabetes

Semaglutide (Ozempic) was approved in 2017, placing it on the list of drugs subject to negotiation for the first time in 2025

First described by Raun et al